AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MAUI, HAWAII -- An open-label trial of adapalene gel 0.3% offered a rare long-term look at efficacy beyond the standard duration of most clinical acne medication trials.
"Most of the trials that we do with retinoids or topical acne treatments are for 12 weeks, and you often wonder what happens to the patient after that 12 weeks," Diane M. Thiboutot, M.D., said at an annual Hawaii dermatology seminar sponsored by the Skin Disease Education Foundation.
A 1-year, open-label, 277-patient trial sponsored by Gal-derma Laboratories found that lesion counts continue to improve beyond the 50%-55% reduction from baseline seen at 12 weeks. By 52 weeks, lesion counts had declined 80% from baseline.
Dryness was reported by ...